Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin in Early Acute Pancreatitis
NCT05637281Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of indomethacin in acute pancreatitis (AP) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Systemic Inflammatory Response Syndrome Score at 72 hours. Status: unknown.
02
Drugs
indomethacin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT05637281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637281.